Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis.
We have previously shown that the inhibition of MNU-induced DNA repair by arsenite occurs after the incision step in Chinese hamster V79 cells. We now report that nuclear DNA ligase activity is inhibited after arsenite treatment and that the inhibited activity is mostly DNA ligase II. Both constitutive and MNU-inducible levels of DNA ligase II are inhibited. The addition of arsenite in vitro also indicates that DNA ligase II is more sensitive to arsenite inhibition than DNA ligase I. Since DNA ligase II is reported to be involved in the ligation step of excision repair, its inhibition by arsenite is a likely mechanism for the inhibition of DNA repair by arsenite and may account for the fact that arsenite acts as a comutagen with a number of different types of mutagens. The carcinogenicity of arsenite may also be a result of ligase inhibition.
Li
J H
JH
Institute of Environmental Medicine, New York University Medical Center, Tuxedo 10987.
Rossman
T G
TG
D000818:Animals; D001151:Arsenic / Q000494:pharmacology* / Q000633:toxicity; D018053:Arsenites; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects / Q000201:enzymology; D000072481:DNA Ligase ATP; D011088:DNA Ligases / Q000037:antagonists & inhibitors*; D004260:DNA Repair / Q000187:drug effects*; D004347:Drug Interactions; D008770:Methylnitrosourea / Q000494:pharmacology; D009153:Mutagens; D011118:Polynucleotide Ligases / Q000037:antagonists & inhibitors*
D018053:Arsenites; D009153:Mutagens; D008770:Methylnitrosourea; D011088:DNA Ligases; D011118:Polynucleotide Ligases; D000072481:DNA Ligase ATP; C015001:arsenite; D001151:Arsenic